Top compounds associated with response to AC009133.22


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA Bleomycin CTRPv2 pan-cancer AAC -0.15 0.0002
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.0006
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0008
mRNA bendamustine CTRPv2 pan-cancer AAC -0.13 0.002
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.003
mRNA BRD-K11533227 CTRPv2 pan-cancer AAC -0.11 0.004
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.091 0.004
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.1 0.005
mRNA PF-184 CTRPv2 pan-cancer AAC -0.097 0.006
Download CSV